Here are the latest quarterly results of ASPIRA PATHLAB & DIAGNOSTICS . For more details, see the ASPIRA PATHLAB & DIAGNOSTICS financial fact sheet and ASPIRA PATHLAB & DIAGNOSTICS share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Dec-22* |
3
Mar-23* |
3
Jun-23* |
3
Sep-23* |
3
Dec-23* |
3
Mar-24* |
3
Jun-24* |
3
Sep-24* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 44 | 34 | 26 | 33 | 35 | 38 | 46 | 62 | |
Other income | Rs m | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
Turnover | Rs m | 45 | 35 | 27 | 35 | 36 | 39 | 47 | 63 | |
Expenses | Rs m | 36 | 33 | 29 | 37 | 38 | 39 | 43 | 48 | |
Gross profit | Rs m | 8 | 1 | -3 | -4 | -4 | -1 | 4 | 14 | |
Depreciation | Rs m | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | |
Interest | Rs m | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
Profit before tax | Rs m | 4 | -3 | -7 | -7 | -7 | -5 | -0 | 10 | |
Tax | Rs m | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Profit after tax | Rs m | 4 | -3 | -7 | -7 | -7 | -5 | -0 | 10 | |
Gross profit margin | % | 18.7 | 4.1 | -12.5 | -11.1 | -10.7 | -3.1 | 7.5 | 21.9 | |
Effective tax rate | % | 0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | 0.0 | |
Net profit margin | % | 10.1 | -7.6 | -27.5 | -21.4 | -21.4 | -13.2 | -0.3 | 16.0 | |
Diluted EPS | Rs | 0.4 | -0.3 | -0.7 | -0.7 | -0.7 | -0.5 | -0.0 | 1.0 | |
Diluted EPS (TTM) | Rs | 1.6 | -0.1 | -0.5 | -1.2 | -2.4 | -2.6 | -1.9 | -0.3 | |
Subscriber Feature |
After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.